The opportunity within the next generation sequencing (NGS) kits market - Roots Analysis

Comments · 262 Views

Roots Analysis has announced the addition of “Next Generation Sequencing Kits Market, 2021 – 2035” report to its list of offerings.


NGS library preparation kit providers are constantly innovating their products to construct high-quality and efficient nucleotide libraries; the ongoing efforts are to bring a paradigm shift in biomarker research, cancer therapy, diagnostics and personalized medicine


Roots Analysis has announced the addition of “Next Generation Sequencing Kits Market, 2021 – 2035” report to its list of offerings.


Despite the recent advances in the field of genomics, the nucleotide library preparation process is still associated with several challenges, including requirement of large amounts of starting materials, time-consuming steps, low volume of yield and concerns related to the quality of product. Presently, a number of players are offering products that are capable of mitigating the aforementioned challenges.


To order this 200+ page report, which features 70+ figures and 120+ tables, please visit


Key Market Insights


More than 280 NGS library preparation kits are currently available in the market

Presently, 73% of the NGS library preparation kits sequence DNA libraries, while 26% sequence RNA libraries. It is important to highlight that majority (52%) of the kits require input samples of less than 5 ng, followed by kits requiring input samples in the range of 5 ng to 10 ng (27%) and more than 10 ng (21%).


Over 55 companies, across the world, claim to offer NGS library preparation kits

Majority of the firms (36%) engaged in this domain are small players, followed by mid-sized and very large companies (30% each). Around 45% of the stakeholders were established before 2001. Further, 63% players are based in North America; within this region, the US emerged as a most prominent hub.


3,200+ patents related to NGS library preparation kits have been granted / filed in 2020 and 2021

RD activity related to NGS kits is largely concentrated in North America, considering the fact that 50% of the total number of patents were filed in this region. In addition, most of the patents in this domain are patent applications (90%), followed by granted patents (9%).


North America and Europe are anticipated to capture ~75% of the market share by 2035

It is worth mentioning that the market in Asia Pacific is expected to grow at a relatively faster pace (19.5%). The current market is driven by sales of DNA library preparation kits (75%), however, in the coming few years, this trend is likely to change owing to the increased demand for RNA therapeutics. Further, hospitals and clinics presently capture 45% of the overall market share (in terms of sales revenues).


Key Questions Answered

  • Who are the key players engaged in offering NGS library preparation kits?
  • What is the relative competitiveness of different NGS library preparation kits?
  • How is the intellectual property landscape for next generation sequencing kits likely to evolve in the foreseen future?
  • What are the factors that are likely to influence the evolution of this market?
  • How is the current and future market opportunity likely to be distributed across key segments?


The financial opportunity within the NGS library preparation kits market has been analyzed across the following segments:

  • Type of Nucleotide Sequenced
  • DNA
  • RNA


  • Type of End User
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Others


  • Key Geographical Regions 
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World 


The research includes profiles of key players (listed below); each profile features a brief overview of the company, its financial performance (if available), recent developments and an informed future outlook.

  • Abcam
  • Agilent Technologies
  • BioDynami
  • Creative Biogene
  • Devyser
  • Diagenode
  • Enzynomics
  • Lexogen
  • MGI
  • New England Biolabs
  • PerkinElmer
  • Roche
  • Takara Bio
  • Tecan
  • Thermo Fisher Scientific
  • TIANGEN Biotech
  • TransGen Biotech
  • Vazyme


For additional details, please visit or email




Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091